With money from QVT, a hedge fund, Vivek’s company purchased a failed drug from GSK, renamed it, and performed a non-scientific post-hoc analysis of the failed drug where they cherry picked data and spun it to pump up the company’s stock. Once the stock price soared after the hysterical mass media, such as CNBC, talked …
Continue reading “The Pump-and-Dump Scammer, Vivek Ramaswamy”
Stem Cells, Health, Technology 